COVID-19: Melatonin as a potential adjuvant treatment
Review article
[키워드] acute lung injury
Anti-inflammatory
anti-oxidative
Anxiety
ARDS
benefit
caused
Clinical features
Clinical outcome
clinical study
contribute
coronavirus
COVID-19
COVID-19 pathology
COVID-19 patients
critical care patient
Cytokine storm
Cytokines
death
disease
distress
effective
Evidence
exaggerated immune response
excessive inflammation
experiment
homogenous
immunomodulation
infected patients
limit
melatonin
outbreak
Oxidation-reduction
pandemic
Pathogenesis
Pathogens
pathology
progression
Protective
reducing
required
respiratory disorder
safety profile
SARS-CoV-2
Sedation
subsequent
syndrome
Treatment
vessel
[DOI] 10.1016/j.lfs.2020.117583 [Article Type] Review article
[DOI] 10.1016/j.lfs.2020.117583 [Article Type] Review article